Mtldl detection to diagnose childhood tuberculosis
Ended Project Grant Awarded Last action
- Award ID
- R41AI136071
- Recipient
-
Chronus Pharmaceuticals Inc. UEI PCYJH71MLJY3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,172
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $75,766 | |
| Amendment | $0 | |
| Original award | $223,406 |
Show all 11
Quick answers
Who received award R41AI136071?
R41AI136071 was awarded to Chronus Pharmaceuticals Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 1, 2018.
How much is award R41AI136071 worth?
$299,172 has been obligated on R41AI136071.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award